Search Results 1001-1010 of 7923 for 谷歌搜索留痕工具咨询邮箱：lgooxc@hotmail.com
Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and ...
This study is being conducted in order to better understand the biology of scleromyxedema in hope of discovering markers that might give diagnostic and ...
The purpose of this study is to investigate if blood and/or MRI markers of inflammation and immune system activation may show changes in relation to when you ...
Investigator, Patent Title, Patent Number, Patent Date. Arthur Beyder Frederick Sachs, Oscillator and method of making for atomic force microscope and other ...
The purpose of this study is to evaluate qualtiy of life (QOL) metrics while receiving subcutaneous (SQ) daratumumab, patient satisfaction, and patient ...
This randomized phase III trial studies how well olanzapine, with or without fosaprepitant, work in preventing chemotherapy induced nausea and vomiting in ...
Mayo Clinic is a nonprofit organization and proceeds from Web advertising help support our mission. Mayo Clinic does not endorse any of the third party products ...
Onvansertib is a drug that binds to and inhibits an enzyme called PLK1, preventing cancer cell proliferation and causing cell death. Participation eligibility.
A Study with to Assess the Effectiveness and Safety of Selexipag as Standard-of-Care Add-on in Subjects with Inoperable or Persistent/Recurrent After-surgical ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Your donation powers the future of medicine and helps save lives.